Details for 2015797762
Up to date per 01.04.2026
Actions
Details for 2015797762
Granted/Registered
European Patent
20.09.2017 A
09.10.2019 B1
10.11.2014
US
201462077672 P
10.11.2014
US
201462077799 P
24.03.2015
US
201562137464 P
C12N 15/113 20100101AFI20160527BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street, 3rd Floor Cambridge, MA 02142US
Representative
Representative
Dipl.-Ing. Dr.techn. Elisabeth SchoberFlorianigasse 26/21080 WienAT
Inventor
HINKLE, Gregory300 Third Street 3rd Floor Cambridge, MA 02142US
SEPP-LORENZINO, Laura300 Third Street 3rd Floor Cambridge, MA 02142US
JADHAV, Vasant300 Third Street 3rd Floor Cambridge, MA 02142US
MAIER, Martin300 Third Street 3rd Floor Cambridge, MA 02142US
MILSTEIN, Stuart300 Third Street 3rd Floor Cambridge, MA 02142US
MANOHARAN, Muthiah300 Third Street 3rd Floor Cambridge, MA 02142US
RAJEEV, Kallanthottathil, G.300 Third Street 3rd Floor Cambridge, MA 02142US
Information about Fees